Toril Holien

Title: Innovator Profile: Toril Holien

Introduction: Toril Holien, a dedicated inventor based in Trondheim, Norway, has made significant contributions to medical technology through her innovative work. With one notable patent to her name, she has advanced the field of extracorporeal photopheresis, a technique with critical implications for patient treatment.

Latest Patents: Toril Holien's patent focuses on the "Modification of extracorporeal photopheresis technology with porphyrin precursors." This invention pertains to the utilization of a photoactivatable Porphyrin-Derivative in extracorporeal photophoresis (ECP) treatment. In this innovative approach, a patient's blood, or a part of it containing the specified Porphyrin-derivative, is exposed to light of a wavelength that activates the photoactivatable Porphyrin-Derivative, paving the way for enhanced therapeutic outcomes.

Career Highlights: Toril is associated with Oslo University Hospital HF, a leading institution in healthcare and medical research. Her work at this esteemed hospital underscores her commitment to improving healthcare technologies and patient care through research and innovation.

Collaborations: Throughout her career, Toril has collaborated with esteemed colleagues, including Qian Peng and Trond Warloe. These partnerships highlight the importance of teamwork and shared expertise in driving advancements in medical technology.

Conclusion: In conclusion, Toril Holien stands out as a key figure in the realm of medical innovation. Her pioneering patent in photopheresis technology reflects her dedication to enhancing treatment modalities. As she continues her work with Oslo University Hospital HF, Toril's contributions are likely to yield significant benefits for patients and the healthcare industry alike.